~~<i id='171E5D9149'><strike id='171E5D9149'><tt id='171E5D9149'><pre id='171E5D9149'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：Wikipedia 2025-09-27 17:09:34 Page View：14925

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug
Next article： 23andMe had bad news about my health. I wish a person had delivered it

leisure time

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

Chemotherapy shortages won’t get better under Biden’s latest plan

PresidentBidenspokeaboutsupplychainresilienceanddrugshortages.AlexWong/GettyImagesWASHINGTON—Preside

Anesthesiologist group: stop taking Ozempic before surgery

EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

Radiology is caught between AI's potential and concern for patients

AdobeRadiologyhaslongledthewayintheapplicationofartificialintelligenceinmedicine.Morethanthree-quart